KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Operating Income: 2017-2025

Historic Operating Income for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $167.0 million.

  • Elanco Animal Health's Operating Income rose 149.25% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 105.29%. This contributed to the annual value of -$1.5 billion for FY2024, which is 51.54% up from last year.
  • Latest data reveals that Elanco Animal Health reported Operating Income of $167.0 million as of Q3 2025, which was down 24.43% from $221.0 million recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's Operating Income peaked at $249.0 million during Q1 2025, and registered a low of -$1.6 billion during Q3 2023.
  • For the 3-year period, Elanco Animal Health's Operating Income averaged around -$364.0 million, with its median value being -$503.0 million (2024).
  • As far as peak fluctuations go, Elanco Animal Health's Operating Income tumbled by 206.98% in 2023, and later soared by 149.50% in 2025.
  • Elanco Animal Health's Operating Income (Quarterly) stood at -$635.0 million in 2021, then climbed by 15.43% to -$537.0 million in 2022, then fell by 19.74% to -$643.0 million in 2023, then rose by 14.15% to -$552.0 million in 2024, then spiked by 149.25% to $167.0 million in 2025.
  • Its Operating Income was $167.0 million in Q3 2025, compared to $221.0 million in Q2 2025 and $249.0 million in Q1 2025.